Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
Clinical trial NCT00104091 · COMPLETED
Trial details
- NCT number
- NCT00104091
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2007-04-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.